Inchcape Plc confirms H1 resilience and FY25 growth outlook

Inchcape plc

Inchcape plc (LON:INCH), the leading global automotive distributor, has provided an update on trading, ahead of the announcement of the Group’s results for the half year ending 30 June 2025, to be published on 29 July 2025.

H1 2025 – resilient operating performance, with continued mixed market momentum and translational currency headwinds:

  • Consistent overall TIV1 trends across Inchcape’s markets throughout H1 2025, with limited tariff-related impact so far
  • Regional operational performance:

– Americas: continued improvement in trading and growth 

– APAC: Australia resilient, with on-going headwinds in certain markets in Asia

– Europe & Africa: continued underlying outperformance of the market

  • Further strategic momentum, with nine distribution contract wins in the year-to-date, including two additional awards2 during Q2 2025
  • Continued translational currency headwinds in key currencies
  • On-going focus on proactive inventory management, cost discipline and capital allocation  

FY 2025 outlook – reiterated:

  • Continue to expect another year of growth, including:

– Expected impact of tariffs on supply, demand and competitive environment in Inchcape’s markets

– Product cycles skewing growth to H2

  • Higher EPS growth expected, driven by profit growth and on-going share buybacks
  • c.£150m of the £250m share buyback programme completed, equivalent to approximately 7% of the Group’s shares in issue, repurchased

1. Total Industry Volumes in Inchcape’s markets (excluding Thailand and Argentina, which are substantial markets where Inchcape volumes are immaterial)

2. New Holland in Kenya and DFSK in Honduras

Share on:
Find more news, interviews, share price & company profile here for:

    UK investment Trust continues impressive gains and beats 12-month index (LON:FSV)

    UK equities advanced in July, supported by trade agreements and earnings upgrades in energy and materials. The Trust’s contrarian approach benefitted from attractive UK valuations, with NAV up 14.1% and the share price up 17.1% over 12 months, compared with a 12.1% gain for the index.

    Fidelity Asian Values reports 17% share price rise over 12 months 

    The Trust’s NAV rose 12.4% over the 12 months to 31 July 2025, ahead of the index at 7.1%, with the share price up 17.0%. Stock selection was the key driver of relative performance, with holdings in China and Hong Kong adding value, while overweight exposure to Indonesia detracted.

    Fidelity Emerging Markets Limited Factsheet: share price continues rise in July

    Emerging markets delivered positive returns in July, marginally ahead of developed markets. The portfolio also gained but underperformed its index, with financials and industrials weighing on performance, while technology stock selection was supportive.

    Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

    Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

    Fidelity China Special Situations factsheet: annual returns rise to 53.9% in July

    China’s stimulus measures supported domestic demand and economic resilience in 2025, with strong industrial production and retail sales. Policy support and fiscal spending helped performance, although challenges in real estate and US-China trade tensions remained.

    HUTCHMED CEO Dr Weiguo Su takes leave of absence

    HUTCHMED (China) has announced that Chief Executive Officer Dr Weiguo Su will take a leave of absence due to health reasons. The Board has appointed Johnny Cheng, the company’s Chief Financial Officer and Executive Director, as Acting CEO while continuing in his CFO role.

      Search

      Search